Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Dresden
Clinical trial register · Germany

Clinical Trials in Dresden, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 22 Essen 10 Dresden 10 Hamburg 9 Hanover 9
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca53 Technische Universität Dresden42 Janssen Research & Development, LLC33 Novartis Pharmaceuticals29 Merck Sharp & Dohme LLC23 Clear sponsor filter
Site location
Berlin22 Essen10 Dresden10 Hamburg9 Hanover9
All 71 locations
Target enrolment
to

Trials with a site in Dresden

10 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Aachen, Bad Oeynhausen, Berlin, Dessau, Dresden, Elsterwerda, Essen, Frankfurt
2026-10-26
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Aachen, Bad Friedrichshall, Bad Oeynhausen, Berlin, Bochum, Coburg, Cologne, Dresden
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Bad Oeynhausen, Berlin, Cologne, Dresden, Frankfurt am Main, Freiburg im Breisgau, Jena, Kiel
2025-10-02
Recruiting
Novo Nordisk A/S
Phase 4
586
Amberg, Bad Mergentheim, Bad Reichenhall, Berlin, Bünde, Daaden, Dortmund, Dresden
2025-08-15
Active, closed
Novo Nordisk A/S
Phase 3
877
Bad Mergentheim, Bad Oeynhausen, Berlin, Bochum, Dresden, Eisenach, Essen, Gelnhausen
2025-08-11
Recruiting
Novo Nordisk A/S
Phase 2
200
Berlin, Dresden, Essen, Frankfurt am Main, Halle, Hanover, Heidelberg, Kiel
2025-06-30
Recruiting
Novo Nordisk A/S
Phase 2
200
Berlin, Dresden, Essen, Frankfurt am Main, Halle, Hanover, Heidelberg, Kiel
2025-06-27
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Bad Berka, Berlin, Bielefeld, Bremen, Cologne, Dachau, Dortmund, Dresden
2024-06-25
Active, closed
Novo Nordisk A/S
Phase 3
673
Bremen, Dresden, Elsterwerda, Erfurt, Frankfurt, Freiburg im Breisgau, Fulda, Homburg
2024-04-01
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Dortmund, Dresden, Elsterwerda, Essen, Frankfurt, Hamburg, Heidelberg, Leipzig
2023-03-01
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/dresden

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Dresden that also match the filters currently applied.

How many clinical trials are recruiting in Dresden?

5 of the 10 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Dresden), 10 studies
PhaseStudiesRecruitingShare
Phase 37270%
Phase 22220%
Phase 41110%

Most active sponsors

Lead sponsors with the most studies (Dresden)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S105
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.